Human Identification Market Projected to Nearly Double, Reaching USD 1390.8 Million by 2031

Standardization Remains a Persistent Challenge The market's biggest structural obstacle is the lack of standardization in technologies, protocols, and regulatory frameworks across different regions and systems.

From solving decades-old cold cases to unlocking a smartphone with a glance, the technology used to verify who someone is has become one of the fastest-evolving corners of forensics and security. A recent industry report values the global human identification market at USD 695.7 million in 2023, projecting growth to USD 756.9 million in 2024 and further to USD 1390.8 million by 2031, a compound annual growth rate of 9.08% across the forecast period. Growing use of forensic investigative genetic genealogy and rising demand for DNA analysis across both forensic and healthcare applications are the primary forces behind this expansion.

What the Market Covers

Human identification encompasses the technologies and solutions used to accurately recognize individuals based on biological, genetic, or biometric data, spanning applications from forensic investigations and law enforcement to healthcare diagnostics, border security, and civil identification. The market's scope continues to widen as advances in DNA analysis, biometrics, and digital forensics open up new use cases, supporting both public safety objectives and personalized medicine initiatives simultaneously.

Security Concerns Are Driving Biometric Adoption

Rising security threats across multiple sectors are a significant driver of demand for human identification technology. As cybercrime and identity theft incidents climb, organizations are increasingly turning to robust identification methods — facial recognition, fingerprint scanning, iris recognition — to protect sensitive data and control access more effectively. This growing emphasis on security is pushing advanced identification systems into a widening range of sectors, including government, financial services, healthcare, education, and transportation, well beyond the technology's traditional forensic and law enforcement roots.

Product innovation is helping extend biometric technology to smaller organizations that previously couldn't afford it. In March 2025, M2SYS launched its M2-LR and M2F PRO-LR terminals specifically to meet demand for affordable human identification solutions among small and mid-sized enterprises, combining fingerprint and facial recognition with anti-spoofing protection and network integration to support secure, efficient workforce management at a lower price point than enterprise-grade systems.

DNA Analysis Is Advancing on Multiple Fronts

DNA analysis remains central to this market's growth, playing a critical role in both forensic investigations and healthcare applications. In forensics, next-generation sequencing technology is enabling more accurate identification from limited or degraded samples, a capability that's proving invaluable in cases where traditional DNA methods fall short. In healthcare, DNA analysis underpins personalized medicine, offering insight into genetic predispositions and supporting earlier disease detection.

Partnerships between technology providers and government agencies are accelerating this progress. In May 2024, QIAGEN partnered with the FBI to develop a digital PCR assay aimed at improving DNA quantification for forensic and healthcare use, enhancing the analysis of challenging forensic samples while supporting next-generation sequencing workflows more broadly.

Forensic Genetic Genealogy Is Solving Cold Cases

One of the most consequential trends in this market is the growing use of forensic investigative genetic genealogy, which combines traditional DNA analysis with public genealogy databases to trace familial connections and identify unknown individuals with far greater accuracy than conventional methods alone. This technique is increasingly being adopted by forensic laboratories worldwide because of its strong track record in resolving cases that had gone cold for years, sometimes decades.

QIAGEN has been particularly active in this space, partnering with the Snow Molecular Anthropology Lab at the University of Montana in July 2024 to advance the identification of human remains, with a particular focus on Indigenous and African American individuals, and supporting development of the first Indigenous-owned DNA database. The company followed this with a September 2024 partnership with Bode Technology to expand use of the GEDmatch PRO forensic genealogy database, aiming to help law enforcement resolve complex and cold cases more efficiently by integrating next-generation sequencing with genetic genealogy techniques.

Standardization Remains a Persistent Challenge

The market's biggest structural obstacle is the lack of standardization in technologies, protocols, and regulatory frameworks across different regions and systems. This fragmentation creates real compatibility issues, hindering the seamless exchange of identification data between agencies, sectors, and countries, and complicating efforts to build unified identification systems at a national or global scale. Companies are addressing this by participating in international working groups focused on developing common standards, while also investing in flexible platforms designed to adapt to varying regulatory and technical requirements across jurisdictions.

Segment Breakdown

By component, consumables led the market in 2023, generating USD 267.5 million in revenue, driven by high demand for DNA testing kits, reagents, and forensic sampling tools across both law enforcement and healthcare settings. By technology, polymerase chain reaction held the largest share at 35.65% in 2023, owing to its reliability, speed, and established role as a standard technique in DNA-based identification. By application, the forensic segment is projected to reach USD 580.3 million by 2031, and by end user, forensic laboratories are expected to grow fastest, at a projected CAGR of 9.20%, supported by rising government funding and modernization of forensic infrastructure worldwide.

Regional Landscape

North America held the largest regional share in 2023, at 35.95% of the global market, equivalent to USD 250.1 million. Rapid integration of biometric and DNA-based identification solutions across law enforcement, healthcare, and finance has reinforced this leadership position, while ongoing investment in AI-powered biometrics and next-generation sequencing technology continues to enhance system accuracy and security across the region.

Asia Pacific is projected to be the fastest-growing region, with a CAGR of 9.96% through 2031 and a forecast market value of USD 346.2 million by that year. The growing use of biometric technology in consumer electronics — particularly smartphones and smart devices equipped with fingerprint and facial recognition — is making the technology increasingly accessible to everyday consumers. Government initiatives promoting digital identity systems and national ID programs are further accelerating adoption, with strategic partnerships helping extend this reach — in November 2024, Aware partnered with Finema to promote biometrics-based digital identity solutions across the region, combining biometric authentication with decentralized identity infrastructure to strengthen digital trust for enterprises and government agencies alike.

Regulatory Landscape

In the United States, the Federal Trade Commission focuses on ensuring consumer privacy, data security, and protection against bias in the use of biometric information, promoting transparency and combating unfair or deceptive data practices. In the European Union, the General Data Protection Regulation, the proposed EU AI Act, the ePrivacy Directive, and national biometric data protection laws work together to ensure privacy, security, and ethical use of biometric technologies while safeguarding consumer rights.

Competitive Landscape

The market includes major players such as Thermo Fisher Scientific Inc., QIAGEN, Promega Corporation, ANDE, FUJIFILM Wako Pure Chemical Corporation, Bio-Rad Laboratories Inc., IDEMIA, Cognitec Systems GmbH, Daon Inc., Aware Inc., Precise Biometrics, and ZKTECO CO. LTD. Recent product developments highlight the sector's rapid pace of innovation: Precise Biometrics secured approval for its BioLive anti-spoofing technology to integrate with India's Aadhaar ID system in March 2025, while authID introduced PrivacyKey in January 2025, a biometric authentication solution that uses public-private key cryptography to verify identity without storing sensitive biometric data at all — directly addressing the privacy concerns that have historically slowed broader biometric adoption.

Outlook

With a projected CAGR of 9.08% through 2031, the human identification market is set to nearly double in size, propelled by advancing DNA technology, expanding biometric adoption across consumer electronics, and growing government investment in digital identity infrastructure. As forensic genetic genealogy continues resolving previously unsolvable cases and privacy-preserving biometric technology addresses lingering consumer trust concerns, this market's growth trajectory looks well supported heading into the next decade.